BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30243299)

  • 1. Spermatogenesis improved by suppressing the high level of endogenous gonadotropins in idiopathic non-obstructive azoospermia: a case control pilot study.
    Hu X; Ding Z; Hong Z; Zou Z; Feng Y; Zhu R; Ma J; Ge X; Li C; Yao B
    Reprod Biol Endocrinol; 2018 Sep; 16(1):91. PubMed ID: 30243299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.
    Hussein A; Ozgok Y; Ross L; Rao P; Niederberger C
    BJU Int; 2013 Mar; 111(3 Pt B):E110-4. PubMed ID: 22958644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of human chorionic gonadotropin-based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive azoospermia.
    Shinjo E; Shiraishi K; Matsuyama H
    Andrology; 2013 Nov; 1(6):929-35. PubMed ID: 24123916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia.
    Shiraishi K; Ohmi C; Shimabukuro T; Matsuyama H
    Hum Reprod; 2012 Feb; 27(2):331-9. PubMed ID: 22128297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of human chorionic gonadotropin on testicular interstitial tissues in men with non-obstructive azoospermia.
    Oka S; Shiraishi K; Matsuyama H
    Andrology; 2017 Mar; 5(2):232-239. PubMed ID: 27860441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of testicular androgen receptor in non-obstructive azoospermia and its change after hormonal therapy.
    Kato Y; Shiraishi K; Matsuyama H
    Andrology; 2014 Sep; 2(5):734-40. PubMed ID: 24919724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic caput epididymis diameter is reduced in non-obstructive azoospermia compared with normozoospermia but is not predictive for successful sperm retrieval after TESE.
    Pezzella A; Barbonetti A; D'Andrea S; Necozione S; Micillo A; Di Gregorio A; Francavilla F; Francavilla S
    Hum Reprod; 2014 Jul; 29(7):1368-74. PubMed ID: 24812316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin B in seminiferous tubules of human testes in normal spermatogenesis and in idiopathic infertility.
    Demyashkin GA
    Syst Biol Reprod Med; 2019 Feb; 65(1):20-28. PubMed ID: 29886763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular histopathology as a predictor of a positive sperm retrieval in men with non-obstructive azoospermia.
    Abdel Raheem A; Garaffa G; Rushwan N; De Luca F; Zacharakis E; Abdel Raheem T; Freeman A; Serhal P; Harper JC; Ralph D
    BJU Int; 2013 Mar; 111(3):492-9. PubMed ID: 22583840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seminal plasma inhibin-B level is a useful predictor of the success of conventional testicular sperm extraction in patients with non-obstructive azoospermia.
    Nagata Y; Fujita K; Banzai J; Kojima Y; Kasima K; Suzuki M; Tanaka K
    J Obstet Gynaecol Res; 2005 Oct; 31(5):384-8. PubMed ID: 16176504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological evaluation of spermatogenesis: a novel and simple diagnostic method to assess spermatogenesis in non-obstructive azoospermia using testicular sperm extraction specimens.
    Hessel M; de Vries M; D'Hauwers KW; Fleischer K; Hulsbergen-van de Kaa CA; Braat DD; Ramos L
    Andrology; 2015 May; 3(3):481-90. PubMed ID: 25858240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trigger effect of hMG and hCG in the treatment of unexplainable non-obstructive azoospermia].
    Hu HR; Nie HC; Yang WM; Sun Y; Huang H; Xie FG
    Zhonghua Nan Ke Xue; 2017 Sep; 23(9):813-816. PubMed ID: 29726663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Level of serum inhibin B for predicting the results of testicular sperm extraction in azoospermia patients].
    Shi L; Li WW; Zhou X; Xu ZP; Zhang CH
    Zhonghua Nan Ke Xue; 2016 Dec; 22(12):1095-1098. PubMed ID: 29282914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
    Raivio T; Wikström AM; Dunkel L
    Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible relationship between seminal plasma inhibin B and spermatogenesis in patients with azoospermia.
    El Garem YF; El Arini AF; El Beheiry AH; Zeid SA; Comhaire FH
    J Androl; 2002; 23(6):825-9. PubMed ID: 12399529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the high endogenous levels of plasma FSH in infertile men are associated with improved Sertoli cell function as reflected by elevated levels of plasma inhibin B.
    Foresta C; Bettella A; Spolaore D; Merico M; Rossato M; Ferlin A
    Hum Reprod; 2004 Jun; 19(6):1431-7. PubMed ID: 15117900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of serum inhibin B and follicle-stimulating hormone levels can not improve the diagnostic accuracy on testicular sperm extraction outcomes in Chinese non-obstructive azoospermic men.
    Huang X; Bai Q; Yan LY; Zhang QF; Geng L; Qiao J
    Chin Med J (Engl); 2012 Aug; 125(16):2885-9. PubMed ID: 22932085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) treatment in gonadotropin-deficient males with pituitary dwarfism.
    Tanaka T; Hibi I; Tanae A
    Acta Paediatr Jpn; 1992 Apr; 34(2):243-8; discussion 249-50. PubMed ID: 1621528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.